Biostress Lab Ltd 12954797 false 2024-01-01 2024-12-31 2024-12-31 The principal activity of the company is the provision of research and analytical services. Digita Accounts Production Advanced 6.30.9574.0 true true 12954797 2024-01-01 2024-12-31 12954797 2024-12-31 12954797 bus:OrdinaryShareClass1 bus:Non-cumulativeNon-redeemableShares 2024-12-31 12954797 bus:OrdinaryShareClass2 bus:Non-cumulativeNon-redeemableShares 2024-12-31 12954797 core:RetainedEarningsAccumulatedLosses 2024-12-31 12954797 core:ShareCapital 2024-12-31 12954797 core:SharePremium 2024-12-31 12954797 core:CurrentFinancialInstruments 2024-12-31 12954797 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 12954797 core:FurnitureFittingsToolsEquipment 2024-12-31 12954797 core:OtherPropertyPlantEquipment 2024-12-31 12954797 bus:SmallEntities 2024-01-01 2024-12-31 12954797 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 12954797 bus:FilletedAccounts 2024-01-01 2024-12-31 12954797 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 12954797 bus:RegisteredOffice 2024-01-01 2024-12-31 12954797 bus:Director1 2024-01-01 2024-12-31 12954797 bus:Director2 2024-01-01 2024-12-31 12954797 bus:OrdinaryShareClass1 bus:Non-cumulativeNon-redeemableShares 2024-01-01 2024-12-31 12954797 bus:OrdinaryShareClass2 bus:Non-cumulativeNon-redeemableShares 2024-01-01 2024-12-31 12954797 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 12954797 core:FurnitureFittingsToolsEquipment 2024-01-01 2024-12-31 12954797 core:OtherPropertyPlantEquipment 2024-01-01 2024-12-31 12954797 core:PlantMachinery 2024-01-01 2024-12-31 12954797 countries:EnglandWales 2024-01-01 2024-12-31 12954797 2023-12-31 12954797 core:FurnitureFittingsToolsEquipment 2023-12-31 12954797 core:OtherPropertyPlantEquipment 2023-12-31 12954797 2023-01-01 2023-12-31 12954797 2023-12-31 12954797 bus:OrdinaryShareClass1 bus:Non-cumulativeNon-redeemableShares 2023-12-31 12954797 bus:OrdinaryShareClass2 bus:Non-cumulativeNon-redeemableShares 2023-12-31 12954797 core:RetainedEarningsAccumulatedLosses 2023-12-31 12954797 core:ShareCapital 2023-12-31 12954797 core:SharePremium 2023-12-31 12954797 core:CurrentFinancialInstruments 2023-12-31 12954797 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 12954797 core:FurnitureFittingsToolsEquipment 2023-12-31 12954797 core:OtherPropertyPlantEquipment 2023-12-31 12954797 bus:OrdinaryShareClass2 bus:Non-cumulativeNon-redeemableShares 2023-01-01 2023-12-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 12954797

Biostress Lab Ltd

Annual Report and Unaudited Financial Statements

for the Year Ended 31 December 2024

 

Biostress Lab Ltd

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

4 to 8

 

Biostress Lab Ltd

Company Information

Directors

Mr Timothy Wade

Mr Timothy Routledge

Registered office

39 Old Heybeck Lane
Tingley
Wakefield
West Yorkshire
WF3 1DW

Accountants

Lucraft Hodgson & Dawes LLP
2/4 Ash Lane
Rustington
West Sussex
BN16 3BZ

 

Biostress Lab Ltd

(Registration number: 12954797)
Balance Sheet as at 31 December 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

4

5,314

8,099

Current assets

 

Debtors

5

54,608

115,549

Cash at bank and in hand

 

3,443

22,531

 

58,051

138,080

Creditors: Amounts falling due within one year

6

(63,535)

(50,943)

Net current (liabilities)/assets

 

(5,484)

87,137

Net (liabilities)/assets

 

(170)

95,236

Capital and reserves

 

Called up share capital

7

116

116

Share premium reserve

267,500

267,500

Profit and loss account

(267,786)

(172,380)

Shareholders' (deficit)/funds

 

(170)

95,236

For the financial year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

 

Biostress Lab Ltd

(Registration number: 12954797)
Balance Sheet as at 31 December 2024

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 13 March 2025 and signed on its behalf by:
 

.........................................
Mr Timothy Wade
Director

 

Biostress Lab Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
39 Old Heybeck Lane
Tingley
Wakefield
West Yorkshire
WF3 1DW
United Kingdom

These financial statements were authorised for issue by the Board on 13 March 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

These financial statements are presented in Sterling, which is also the company's functional currency. The financial statements are rounded to the nearest £1.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

 

Biostress Lab Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

2

Accounting policies (continued)

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Plant and machinery

33% straight line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

 

Biostress Lab Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

2

Accounting policies (continued)

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 5 (2023 - 6).

 

Biostress Lab Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

4

Tangible assets

Furniture, fittings and equipment
 £

Other tangible assets
£

Total
£

Cost or valuation

At 1 January 2024

11,133

21,707

32,840

At 31 December 2024

11,133

21,707

32,840

Depreciation

At 1 January 2024

3,034

21,707

24,741

Charge for the year

2,785

-

2,785

At 31 December 2024

5,819

21,707

27,526

Carrying amount

At 31 December 2024

5,314

-

5,314

At 31 December 2023

8,099

-

8,099

5

Debtors

Current

2024
£

2023
£

Trade debtors

4,800

-

Other debtors

49,808

115,549

 

54,608

115,549

 

Biostress Lab Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

6

Creditors

Creditors: amounts falling due within one year

Note

2024
£

2023
£

Due within one year

 

Loans and borrowings

8

33

6,033

Trade creditors

 

-

2,011

Taxation and social security

 

1,506

11,003

Accruals and deferred income

 

2,600

2,500

Other creditors

 

59,396

29,396

 

63,535

50,943

7

Share capital

Allotted, called up and fully paid shares

 

2024

2023

 

No.

£

No.

£

Ordinary shares of £0.00025 each

464,030

116

464,030

116

Ordinary B shares of £0.00025 (2023 - £0) each

878

-

-

-

 

464,908

116

464,030

116

8

Loans and borrowings

2024
£

2023
£

Current loans and borrowings

Other borrowings

33

6,033

33

6,033